Cadit Pharma Private Limited
About Cadit Pharma Private Limited
Data last updated:
Cadit Pharma Private Limited is a private limited company based in Patna, Bihar, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 23 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24100BR2019PTC043434. Its GSTIN is 10AAICC3918L1ZR (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepak Kumar and Priyanka Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/Oanands/Orajendrayadav Near Patna Central School New Jaganpura New Kemnichak, Bihar, India – 800027.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.27 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net profit of ₹1,905 (net margin 0.6%) and EBITDA of ₹10,181 (EBITDA margin 3.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/Oanands/Orajendrayadav Near Patna Central School New Jaganpura New Kemnichak, Bihar, India – 800027
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cadit Pharma Private Limited
The main business activity of Cadit Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cadit Pharma Private Limited FY 2025 filings available
Cadit Pharma Private Limited reported revenue of ₹3.27 Lakh (down 55% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Cadit Pharma Private Limited
Revenue fell 55% in the latest year. EBITDA fell 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cadit Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10,181 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,905 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cadit Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cadit Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cadit Pharma Private Limited
Cadit Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eshan Technosy Private Limited | ₹3.28 Lakh (FY 2024) | •••• | •••• | •••• | G B Nagar, Uttar Pradesh, India | |
| Aaps Resource Private Limited | ₹3.28 Lakh (FY 2023) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Gajmurti Commodities Limited | ₹3.27 Lakh (FY 2018) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Gangotri Tradecomm Private Limited | ₹3.27 Lakh (FY 2025) | •••• | •••• | 82.0% | •••• | Kolkata, West Bengal, India |
| Jyoti Highrise Private Limited | ₹3.27 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Kolkata, West Bengal, India |
| Cadit Pharma Private Limited this company | ₹3.27 Lakh (FY 2024) | •••• | •••• | -55.0% | •••• | Patna, Bihar, India |
| Ample Nutrition Products Private Limited | ₹3.27 Lakh (FY 2018) | •••• | •••• | -97.0% | •••• | Morena, Madhya Pradesh, India |
| Itncs Traders (OPC) Private Limited | ₹3.27 Lakh (FY 2019) | •••• | •••• | •••• | Moga, Punjab, India | |
| Dhatri Laxmi Private Limited | ₹3.27 Lakh (FY 2024) | •••• | •••• | -26.0% | •••• | Jajpur Road, Odisha, India |
| Young IT Minds Private Limited | ₹3.27 Lakh (FY 2024) | •••• | •••• | 136.0% | •••• | New Delhi, Delhi, India |
| Nvedas Technologies Private Limited | ₹3.27 Lakh (FY 2020) | •••• | •••• | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Cadit Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Cadit Pharma Private Limited
Cadit Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar | Director | 23 Sep 2019 | 7 Years 0 Months | Current |
| Priyanka Kumari | Director | 23 Sep 2019 | 7 Years 0 Months | Current |
Ownership and Shareholding of Cadit Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cadit Pharma Private Limited
Cadit Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cadit Pharma Private Limited
Employment history and EPFO contributions of people linked to Cadit Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cadit Pharma Private Limited
Cadit Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Deepak Kumar was appointed as Director on 23 Sep 2019.
Credit Ratings, Litigation & Regulatory Alerts for Cadit Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cadit Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cadit Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cadit Pharma Private Limited
Cadit Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAICC3918L1ZR | Bihar | Active | 20 Oct 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cadit Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cadit Pharma Private Limited
Cadit Pharma is an active private limited company based in Patna, Bihar, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 23 September 2019 (7+ years old) and is registered under CIN U24100BR2019PTC043434.
Cadit Pharma reported revenue of ₹3.27 Lakh for FY 2024 (down 55% YoY).
Cadit Pharma has 2 current directors:
- Deepak Kumar - Director
- Priyanka Kumari - Director
Cadit Pharma reported a net profit of ₹1,905 (net margin 0.6%) and EBITDA of ₹10,181 (EBITDA margin 3.1%) for FY 2024, as per its filed financial statements.
The GSTIN of Cadit Pharma is 10AAICC3918L1ZR, registered in Bihar.
The CIN (Corporate Identification Number) of Cadit Pharma is U24100BR2019PTC043434. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cadit Pharma was incorporated on 23 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Cadit Pharma by revenue are Eshan Technosy Private Limited, Aaps Resource Private Limited, Gajmurti Commodities Limited, Gangotri Tradecomm Private Limited, Jyoti Highrise Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Deepak Kumar was appointed as Director on 23 Sep 2019. Priyanka Kumari was appointed as Director on 23 Sep 2019.
The registered office of Cadit Pharma is at COanandsOrajendrayadav Near Patna Central School New Jaganpura New Kemnichak, Bihar, India – 800027.
Cadit Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.